Notice
Instant 25% OFF! – Add to Cart to See Discount good for a Limited Time! (Can't be combined with other promos)
Description
Pinnacle I.N. to help protect horses against strangles, look to PINNACLE® I.N. –the only two-dose, modified-live bacterial vaccine developed to help prevent strangles caused by Streptococcus equi (S. equi).
Strangles is a highly contagious upper respiratory infection most common in young horses. Strangles symptoms can include fever, difficulty swallowing, abnormal breathing, nasal discharge, swelling and/or abscesses of the lymph nodes.1 The disease can spread quickly and is easily transmitted through direct animal-to-animal contact or by objects — buckets, bridles or human hands — that have come in contact with infected horses. Your horse may be at risk for strangles if he travels to events or shows or is exposed to unfamiliar horses, such as within a boarding barn.
Strangles is a highly contagious upper respiratory infection most common in young horses. Strangles symptoms can include fever, difficulty swallowing, abnormal breathing, nasal discharge, swelling and/or abscesses of the lymph nodes.1 The disease can spread quickly and is easily transmitted through direct animal-to-animal contact or by objects — buckets, bridles or human hands — that have come in contact with infected horses. Your horse may be at risk for strangles if he travels to events or shows or is exposed to unfamiliar horses, such as within a boarding barn.
- The only two-dose modified-live vaccine developed to help prevent strangles caused by S. equi.
- Intranasal administration helps provide a more natural immune response, stimulating innate andmucosal immunity at the site of natural infection.
- PINNACLE I.N. utilizes a specially designed cannula that helps deliver the vaccine to the pharyngeal (throat) area.
- Because it is given intranasally, PINNACLE I.N. avoids local injection-site reactions that can occur with parenteral S. equi vaccines.2
Useful Information
Aseptically rehydrate with the entire contents of the accompanying sterile diluent. Instill the entire rehydrated vaccine into one nostril using a syringe with applicator tip. Administer a second dose two to three weeks later. Annual revaccination is recommended.
For intranasal use only. Do not administer by any other route than intranasal.
Always read and follow label indications.
CAUTIONS this product contains live bacteria and is designed for intranasal use only. Disinfect hands and equipment after use. Contamination of the user
For intranasal use only. Do not administer by any other route than intranasal.
Always read and follow label indications.
CAUTIONS this product contains live bacteria and is designed for intranasal use only. Disinfect hands and equipment after use. Contamination of the user